HCV animal models and liver disease

Area of Science:

• Hepatology and Virology
• Infectious Diseases and Immunology
• Animal Models in Biomedical Research

Background:

• Studying hepatitis C virus (HCV) and developing therapies has been challenging due to the lack of suitable small animal models.
• HCV exhibits narrow host tropism, limiting its study in traditional animal systems.
• Previous models could not fully recapitulate the HCV life cycle or host interactions.

Purpose of the Study:

• To review the evolution of in vivo models for studying the hepatitis C virus (HCV).
• To highlight the development and utility of human hepatocyte-engrafted mouse models for HCV research.
• To discuss the limitations of current models in studying cellular immunity and immunopathogenesis of HCV.

Main Methods:

• Development of immunodeficient mouse models engrafted with human hepatocytes.
• Utilizing these humanized mice to recapitulate the complete hepatitis C virus (HCV) life cycle.
• Evaluating the efficacy of antiviral interventions in these established models.

Main Results:

• Humanized mouse models enable robust engraftment and support the complete HCV life cycle.
• These models have been instrumental in investigating antiviral therapies and understanding HCV replication.
• However, the lack of a fully functional immune system in these models limits studies on cellular immunity and immunopathogenesis.

Conclusions:

• The development of human hepatocyte-engrafted mice represents a significant advancement for in vivo hepatitis C virus (HCV) research.
• These models are valuable for studying viral kinetics and evaluating antiviral strategies.
• Further development of small animal models with functional immune systems is needed to fully understand HCV immunopathogenesis and associated liver diseases.